MATERNITY360 ASPIRE
LIVE

Serial Number

99550923

Owner

Medicines360

Attorney

Cecily Anne O'Regan

Filing Date

Dec 16, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MATERNITY360 ASPIRE Trademark

Serial Number: 99550923

MATERNITY360 ASPIRE is a trademark filed by Medicines360 on December 16, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Medicines360 (29 trademarks)

353 Sacramento Street
San Francisco, CA 94111

Entity Type: 99

Trademark Details

Filing Date

December 16, 2025

Registration Date

Not Registered

Published for Opposition

July 7, 2026

Goods & Services

Reagents and assays for scientific and research use

Providing medical information in the field of women’s health, cardiology, endocrinology, gynecology, obstetrics, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, postpartum maternal health, contraception, proteomics and diabetes; Medical diagnostic testing, monitoring and reporting services; providing medical information in the field of medical testing, risk prediction and classification of maternal health conditions and health conditions during pregnancy and labor

Providing medical and scientific research information in the field of women’s health, cardiology, endocrinology, gynecology, obstetrics, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, postpartum maternal health, contraception, proteomics and diabetes; Providing online non-downloadable and downloadable software for medical diagnostic risk prediction, for conducting testing and for recommending medical treatment; Software as a service (SAAS) services featuring software for medical assessment, diagnostic testing and for recommending medical treatment; Providing online non-downloadable software, for medical testing, creating reports for risk prediction and medical classification and for providing information in the field of maternal health and health conditions during pregnancy and labor

Promoting awareness of and organizing and developing projects to support women’s health

Medical diagnostic reagents and assays; medical diagnostic reagents and assays for use in treating, monitoring, testing, analyzing and detecting medical conditions, diseases and disorders in the field of women’s health, cardiology, endocrinology, gynecology, obstetrics, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, postpartum maternal health, contraception, proteomics and diabetes; diagnostic biomarker reagents and assays for medical purposes

Educational services, namely, conducting classes, seminars, conferences, workshops, and online non-downloadable webinars for physicians and other medical service providers to provide instruction on the use of software and medical reagents and assays, and distribution of training materials in connection therewith

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jul 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2026 NONP
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 8, 2026 GNEN
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 8, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 8, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jun 8, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 8, 2026 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 14, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 14, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 14, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 14, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 14, 2026 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 20, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 20, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 20, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 7, 2026 NWOS
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 12, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 12, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 12, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 12, 2026 REAP
APPLICATION FILING RECEIPT MAILED
Dec 16, 2025 MAFR
NEW APPLICATION ENTERED
Dec 16, 2025 NWAP